cognitive impairment
05/02/2017
/
By Amy Goodrich
Dangerous Alzheimer’s treatment drug DONEPEZIL being widely prescribed “off-label” was never approved for such uses by the FDA
Donepezil is an acetylcholinesterase inhibitor approved by the Food and Drug Administration (FDA) in the United States to treat Alzheimer’s disease. Since mild cognitive impairment (MCI), or the phase between normal age-related brain decline and dementia, displays similar symptoms to Alzheimer’s, many physicians also prescribe this drug off-label to patients with MCI. Researchers from the […]
« Return Home
1 of 1
Popular Articles
DEATH BY DOCTOR: Why and how doctors are now PAID TO KILL their patients
April 08, 2025
/
S.D. Wells
Over 60% of Americans are hooked on pharmaceutical drugs: These are the most commonly prescribed drugs and their most pervasive side effects
April 24, 2025
/
Lance D Johnson
The hidden dangers of acetaminophen: Study links long-term use to ORGAN DAMAGE in seniors, but safer remedies are available
April 09, 2025
/
Lance D Johnson
New study links mRNA vaccines to GENETIC CHANGES - and not the good kind
April 08, 2025
/
Ava Grace
Thimerosal is 50 percent MERCURY and NO it has NOT been removed from vaccines - that was a BIG FAT LIE the CDC told vax skeptics to keep them vaxxed up and dying
April 07, 2025
/
S.D. Wells
Shedding light on the dark side of MMR vaccines: How vaccinated individuals SPREAD MEASLES & put the vulnerable at risk
April 11, 2025
/
Lance D Johnson
The unspoken truth about chemotherapy: These “treatments” create toxic time bombs in your body called CELL-KILLING PARTICLES
April 27, 2025
/
Lance D Johnson
COVID mRNA injections linked to genetic changes that increase brain tumor and leukemia risk
April 03, 2025
/
Lance D Johnson
The media playbook for measles looks a lot like its COVID playbook - this time, kids are the pawns
April 10, 2025
/
News Editors
“Rockefeller Medicine Men”: Today’s healthcare crisis stems from the creation of the American medical establishment
April 07, 2025
/
Arsenio Toledo
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy
